Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.

BACKGROUND: Cardiac resynchronization therapy (CRT) has been extensively demonstrated to benefit heart failure patients, but the role of underlying heart failure etiology in the outcomes was not consistently proven. This meta-analysis aimed to determine whether efficacy and effectiveness of CRT is a...

Full description

Bibliographic Details
Main Authors: Yanmei Chen, Chongyang Duan, Feng Liu, Shuxin Shen, Pingyan Chen, Jianping Bin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3986107?pdf=render
_version_ 1818387354230980608
author Yanmei Chen
Chongyang Duan
Feng Liu
Shuxin Shen
Pingyan Chen
Jianping Bin
author_facet Yanmei Chen
Chongyang Duan
Feng Liu
Shuxin Shen
Pingyan Chen
Jianping Bin
author_sort Yanmei Chen
collection DOAJ
description BACKGROUND: Cardiac resynchronization therapy (CRT) has been extensively demonstrated to benefit heart failure patients, but the role of underlying heart failure etiology in the outcomes was not consistently proven. This meta-analysis aimed to determine whether efficacy and effectiveness of CRT is affected by underlying heart failure etiology. METHODS AND RESULTS: Searches of MEDLINE, EMBASE and Cochrane databases were conducted to identify RCTs and observational studies that reported clinical and functional outcomes of CRT in ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM) patients. Efficacy of CRT was assessed in 7 randomized controlled trials (RCTs) with 7072 patients and effectiveness of CRT was evaluated in 14 observational studies with 3463 patients In the pooled analysis of RCTs, we found that CRT decreased mortality or heart failure hospitalization by 29% in ICM patients (95% confidence interval [CI], 21% to 35%), and by 28% (95% CI, 18% to 37%) in NICM patients. No significant difference was observed between the 2 etiology groups (P = 0.55). In the pooled analysis of observational studies, however, we found that ICM patients had a 54% greater risk for mortality or HF hospitalization than NICM patients (relative risk: 1.54; 95% CI: 1.30-1.83; P<0.001). Both RCTs and observational studies demonstrated that NICM patients had greater echocardiographic improvements in the left ventricular ejection fraction and end-systolic volume, as compared with ICM patients (both P<0.001). CONCLUSION: CRT might reduce mortality or heart failure hospitalization in both ICM and NICM patients similarly. The improvement of the left ventricular function and remodeling is greater in NICM patients.
first_indexed 2024-12-14T04:08:36Z
format Article
id doaj.art-082985e6e3c14dfc9ce48fa7c613eca7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T04:08:36Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-082985e6e3c14dfc9ce48fa7c613eca72022-12-21T23:17:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9461410.1371/journal.pone.0094614Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.Yanmei ChenChongyang DuanFeng LiuShuxin ShenPingyan ChenJianping BinBACKGROUND: Cardiac resynchronization therapy (CRT) has been extensively demonstrated to benefit heart failure patients, but the role of underlying heart failure etiology in the outcomes was not consistently proven. This meta-analysis aimed to determine whether efficacy and effectiveness of CRT is affected by underlying heart failure etiology. METHODS AND RESULTS: Searches of MEDLINE, EMBASE and Cochrane databases were conducted to identify RCTs and observational studies that reported clinical and functional outcomes of CRT in ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM) patients. Efficacy of CRT was assessed in 7 randomized controlled trials (RCTs) with 7072 patients and effectiveness of CRT was evaluated in 14 observational studies with 3463 patients In the pooled analysis of RCTs, we found that CRT decreased mortality or heart failure hospitalization by 29% in ICM patients (95% confidence interval [CI], 21% to 35%), and by 28% (95% CI, 18% to 37%) in NICM patients. No significant difference was observed between the 2 etiology groups (P = 0.55). In the pooled analysis of observational studies, however, we found that ICM patients had a 54% greater risk for mortality or HF hospitalization than NICM patients (relative risk: 1.54; 95% CI: 1.30-1.83; P<0.001). Both RCTs and observational studies demonstrated that NICM patients had greater echocardiographic improvements in the left ventricular ejection fraction and end-systolic volume, as compared with ICM patients (both P<0.001). CONCLUSION: CRT might reduce mortality or heart failure hospitalization in both ICM and NICM patients similarly. The improvement of the left ventricular function and remodeling is greater in NICM patients.http://europepmc.org/articles/PMC3986107?pdf=render
spellingShingle Yanmei Chen
Chongyang Duan
Feng Liu
Shuxin Shen
Pingyan Chen
Jianping Bin
Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.
PLoS ONE
title Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.
title_full Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.
title_fullStr Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.
title_full_unstemmed Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.
title_short Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis.
title_sort impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy a meta analysis
url http://europepmc.org/articles/PMC3986107?pdf=render
work_keys_str_mv AT yanmeichen impactofetiologyontheoutcomesinheartfailurepatientstreatedwithcardiacresynchronizationtherapyametaanalysis
AT chongyangduan impactofetiologyontheoutcomesinheartfailurepatientstreatedwithcardiacresynchronizationtherapyametaanalysis
AT fengliu impactofetiologyontheoutcomesinheartfailurepatientstreatedwithcardiacresynchronizationtherapyametaanalysis
AT shuxinshen impactofetiologyontheoutcomesinheartfailurepatientstreatedwithcardiacresynchronizationtherapyametaanalysis
AT pingyanchen impactofetiologyontheoutcomesinheartfailurepatientstreatedwithcardiacresynchronizationtherapyametaanalysis
AT jianpingbin impactofetiologyontheoutcomesinheartfailurepatientstreatedwithcardiacresynchronizationtherapyametaanalysis